All Articles

Is nicotinamide adenine dinucleotide the Achilles’ heel of chronic interleukin-6 signaling in cholangiocarcinoma?

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Glucose metabolic dysregulation and oxidative stress in cholangiocarcinoma: molecular mechanisms, oncogenic drivers, and novel therapeutic targets

Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets

The new era of cholangiocarcinoma treatment: application of nano-based drug delivery systems

Glucose addiction of cholangiocarcinoma: opportunities for therapeutic development

Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Evaluation of the outcomes of staging laparoscopy in intrahepatic cholangiocarcinoma patients undergoing surgical resection: a multicenter retrospective study in China

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

Hepatic arterial infusion chemotherapy: a review with technical notes

Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver

The role of percutaneous hepatic perfusion (PHP) in the treatment of cholangiocarcinoma

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy

Targeted mutation-based therapy for intrahepatic cholangiocarcinoma

Treatment of intrahepatic cholangiocarcinoma: evidence for the role of percutaneous ablation